Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Inventory (2022 - 2023)

Amylyx Pharmaceuticals has reported Inventory over the past 2 years, most recently at $38.3 million for Q4 2023.

  • Quarterly results put Inventory at $38.3 million for Q4 2023, up 292.29% from a year ago — trailing twelve months through Dec 2023 was $38.3 million (up 292.29% YoY), and the annual figure for FY2023 was $38.3 million, up 292.29%.
  • Inventory for Q4 2023 was $38.3 million at Amylyx Pharmaceuticals, up from $32.4 million in the prior quarter.
  • Over the last five years, Inventory for AMLX hit a ceiling of $38.3 million in Q4 2023 and a floor of $563000.0 in Q3 2022.